Publicaciones (21) Publicaciones de Federico Nicolas Soria Lannes

2023

  1. Local diffusion in the extracellular space of the brain

    Neurobiology of Disease, Vol. 177

  2. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

    Autophagy, Vol. 19, Núm. 7, pp. 1952-1981

2022

  1. Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function

    Aging Cell, Vol. 21, Núm. 4

2021

  1. Super-resolution STED microscopy in live brain tissue

    Neurobiology of Disease, Vol. 156

2020

  1. Current Techniques for Investigating the Brain Extracellular Space

    Frontiers in Neuroscience, Vol. 14

  2. Nanoscale exploration of the extracellular space in the live brain by combining single carbon nanotube tracking and super-resolution imaging analysis

    Methods, Vol. 174, pp. 91-99

  3. Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism

    Translational Psychiatry, Vol. 9, Núm. 1

2018

  1. Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases

    Bioconjugate Chemistry, Vol. 29, Núm. 12, pp. 4083-4089

  2. Synaptic regulator α-synuclein in dopaminergic fibers is essentially required for the maintenance of subependymal neural stem cells

    Journal of Neuroscience, Vol. 38, Núm. 4, pp. 814-825

2017

  1. Exosomes, an unmasked culprit in neurodegenerative diseases

    Frontiers in Neuroscience, Vol. 11, Núm. JAN

  2. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration

    Human Molecular Genetics, Vol. 26, Núm. 14, pp. 2603-2615

  3. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Cystine/glutamate antiporter blockage induces myelin degeneration

    GLIA, Vol. 64, Núm. 8, pp. 1381-1395

  2. In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Núm. 6, pp. 1124-1138

  3. Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases

    Autophagy, Vol. 12, Núm. 3, pp. 472-483

2014

  1. Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage

    Journal of Clinical Investigation, Vol. 124, Núm. 8, pp. 3645-3655

2013

  1. Zn2+-induced ERK activation mediates PARP-1-dependent ischemic-reoxygenation damage to oligodendrocytes

    GLIA, Vol. 61, Núm. 3, pp. 383-393

2012

  1. Extrahypophyseal expression of gonadotropin subunits in pejerrey Odontesthes bonariensis and effects of high water temperatures on their expression

    General and Comparative Endocrinology, Vol. 175, Núm. 2, pp. 329-336

2011

  1. Increased expression of cystine/glutamate antiporter in multiple sclerosis

    Journal of Neuroinflammation, Vol. 8